Results for “”

Entry Author Date Location
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic 03/23/20 Boston
UCSD, 5 Diagnostic Makers Partner to Ramp COVID-19 Testing Capacity 03/20/20 San Diego
Bio Roundup: Coronavirus Diagnostics, Therapeutics, Vaccines & More 03/20/20 National
Eureka Partners With Lyell to Tackle Tricky Solid Tumor Cell Therapies 03/20/20 San Francisco
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future 03/19/20 Boston
How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns 03/19/20 San Diego
Fears Of Recession Mount As Coronavirus Declared A Pandemic 03/19/20 National
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening 03/17/20 National
Qiagen Juices RNA Extraction Kit Capacity to Feed Coronavirus Test Needs 03/17/20 National
The Benefits and Impact of Later In-Licensing Deals for Biopharma 03/17/20 National
Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy 03/16/20 Europe
UC San Diego Health Develops COVID-19 Test, Begins Testing Patients 03/14/20 San Diego
Lax Approval Requirements Yield Blockbusters That Don’t Work 03/13/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Rubius Drops Rare Diseases, Turns to Cancer and Autoimmune Disorders 03/12/20 Boston
Harbour BioMed Tacks on $75M to Advance Broad Biologics Pipeline 03/12/20 Boston
Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO 03/12/20 Boston
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Xcelerating Life Sciences San Diego Will Be Delivered Digitally 03/11/20 National
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund 03/11/20 Europe
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug 03/11/20 Seattle
Acceleron Drops Drug for Rare Muscle Disease After Mixed Phase 2 Data 03/10/20 Boston
Kala to Take Another Shot at FDA Approval With New Dry Eye Drug Data 03/09/20 Boston
Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod 03/09/20 Europe
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects 03/05/20 San Diego
Culture Biosciences Adds $15M for New Software, Bioreactor Expansion 03/05/20 San Francisco
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Page 2 of 1962 « previous page · next page »